Atlas Trials

A Study of Avastin (Bevacizumab) Added to a Chemotherapeutic Regimen in Patients With Metastatic Pancreatic Cancer

Clinical trial NCT01214720 · COMPLETED

Trial details

NCT number
NCT01214720
Sponsor
Hoffmann-La Roche
Status
COMPLETED
Phase
Phase 3
Study type
INTERVENTIONAL
Pancreatic Cancer
Start date
2005-07-01
Primary completion
2008-10-01
Enrollment
607

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.